These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11895439)

  • 21. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection.
    Watson KA; Mitchell EP; Johnson LN; Cruciani G; Son JC; Bichard CJ; Fleet GW; Oikonomakos NG; Kontou M; Zographos SE
    Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):458-72. PubMed ID: 15299833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
    Hadjiloi T; Tiraidis C; Chrysina ED; Leonidas DD; Oikonomakos NG; Tsipos P; Gimisis T
    Bioorg Med Chem; 2006 Jun; 14(11):3872-82. PubMed ID: 16464598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors.
    Kun S; Begum J; Kyriakis E; Stamati ECV; Barkas TA; Szennyes E; Bokor É; Szabó KE; Stravodimos GA; Sipos Á; Docsa T; Gergely P; Moffatt C; Patraskaki MS; Kokolaki MC; Gkerdi A; Skamnaki VT; Leonidas DD; Somsák L; Hayes JM
    Eur J Med Chem; 2018 Mar; 147():266-278. PubMed ID: 29453094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.
    Oikonomakos NG; Kontou M; Zographos SE; Watson KA; Johnson LN; Bichard CJ; Fleet GW; Acharya KR
    Protein Sci; 1995 Dec; 4(12):2469-77. PubMed ID: 8580837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New synthesis of 3-(β-D-glucopyranosyl)-5-substituted-1,2,4-triazoles, nanomolar inhibitors of glycogen phosphorylase.
    Kun S; Bokor É; Varga G; Szőcs B; Páhi A; Czifrák K; Tóth M; Juhász L; Docsa T; Gergely P; Somsák L
    Eur J Med Chem; 2014 Apr; 76():567-79. PubMed ID: 24608000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds.
    Watson KA; Mitchell EP; Johnson LN; Son JC; Bichard CJ; Orchard MG; Fleet GW; Oikonomakos NG; Leonidas DD; Kontou M
    Biochemistry; 1994 May; 33(19):5745-58. PubMed ID: 8180201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP.
    Barford D; Hu SH; Johnson LN
    J Mol Biol; 1991 Mar; 218(1):233-60. PubMed ID: 1900534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probing the β-pocket of the active site of human liver glycogen phosphorylase with 3-(C-β-d-glucopyranosyl)-5-(4-substituted-phenyl)-1, 2, 4-triazole inhibitors.
    Kyriakis E; Solovou TGA; Kun S; Czifrák K; Szőcs B; Juhász L; Bokor É; Stravodimos GA; Kantsadi AL; Chatzileontiadou DSM; Skamnaki VT; Somsák L; Leonidas DD
    Bioorg Chem; 2018 Apr; 77():485-493. PubMed ID: 29454281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new allosteric site in glycogen phosphorylase b as a target for drug interactions.
    Oikonomakos NG; Skamnaki VT; Tsitsanou KE; Gavalas NG; Johnson LN
    Structure; 2000 Jun; 8(6):575-84. PubMed ID: 10873856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and Synthesis of 3-(β-d-Glucopyranosyl)-4-amino/4-guanidino Pyrazole Derivatives and Analysis of Their Glycogen Phosphorylase Inhibitory Potential.
    Kun S; Mathomes RT; Docsa T; Somsák L; Hayes JM
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes.
    Martin JL; Veluraja K; Ross K; Johnson LN; Fleet GW; Ramsden NG; Bruce I; Orchard MG; Oikonomakos NG; Papageorgiou AC
    Biochemistry; 1991 Oct; 30(42):10101-16. PubMed ID: 1931942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b.
    Johnson LN; Snape P; Martin JL; Acharya KR; Barford D; Oikonomakos NG
    J Mol Biol; 1993 Jul; 232(1):253-67. PubMed ID: 8331662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, In Silico and Kinetics Evaluation of
    Homolya L; Mathomes RT; Varga L; Docsa T; Juhász L; Hayes JM; Somsák L
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. van der Waals interactions govern C-β-d-glucopyranosyl triazoles' nM inhibitory potency in human liver glycogen phosphorylase.
    Kantsadi AL; Stravodimos GA; Kyriakis E; Chatzileontiadou DSM; Solovou TGA; Kun S; Bokor É; Somsák L; Leonidas DD
    J Struct Biol; 2017 Jul; 199(1):57-67. PubMed ID: 28483603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate.
    Leonidas DD; Oikonomakos NG; Papageorgiou AC; Acharya KR; Barford D; Johnson LN
    Protein Sci; 1992 Sep; 1(9):1112-22. PubMed ID: 1304390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 1.76 A resolution crystal structure of glycogen phosphorylase B complexed with glucose, and CP320626, a potential antidiabetic drug.
    Oikonomakos NG; Zographos SE; Skamnaki VT; Archontis G
    Bioorg Med Chem; 2002 May; 10(5):1313-9. PubMed ID: 11886794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycogen phosphorylase inhibitor N-(3,5-dimethyl-Benzoyl)-N'-(β-D-glucopyranosyl)urea improves glucose tolerance under normoglycemic and diabetic conditions and rearranges hepatic metabolism.
    Nagy L; Docsa T; Szántó M; Brunyánszki A; Hegedűs C; Márton J; Kónya B; Virág L; Somsák L; Gergely P; Bai P
    PLoS One; 2013; 8(7):e69420. PubMed ID: 23936011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The binding of 2-deoxy-D-glucose 6-phosphate to glycogen phosphorylase b: kinetic and crystallographic studies.
    Oikonomakos NG; Zographos SE; Johnson LN; Papageorgiou AC; Acharya KR
    J Mol Biol; 1995 Dec; 254(5):900-17. PubMed ID: 7500360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The binding of C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides to glycogen phosphorylase b: synthesis, biochemical and biological assessment.
    Kantsadi AL; Manta S; Psarra AM; Dimopoulou A; Kiritsis C; Parmenopoulou V; Skamnaki VT; Zoumpoulakis P; Zographos SE; Leonidas DD; Komiotis D
    Eur J Med Chem; 2012 Aug; 54():740-9. PubMed ID: 22770609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylase.
    Oikonomakos NG; Kontou M; Zographos SE; Tsitoura HS; Johnson LN; Watson KA; Mitchell EP; Fleet GW; Son JC; Bichard CJ
    Eur J Drug Metab Pharmacokinet; 1994; 19(3):185-92. PubMed ID: 7867660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.